HomeINMB • NASDAQ
add
INmune Bio Inc
Previous close
$1.13
Day range
$1.15 - $1.25
Year range
$1.09 - $11.64
Market cap
32.70M USD
Avg Volume
550.57K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.47M | -42.18% |
Net income | -5.26M | 42.89% |
Net profit margin | — | — |
Earnings per share | -0.18 | 55.00% |
EBITDA | -5.42M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.75M | 18.30% |
Total assets | 32.35M | -18.23% |
Total liabilities | 8.83M | 18.25% |
Total equity | 23.52M | — |
Shares outstanding | 26.59M | — |
Price to book | 1.28 | — |
Return on assets | -41.65% | — |
Return on capital | -53.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.26M | 42.89% |
Cash from operations | -2.94M | 73.27% |
Cash from investing | -143.00K | — |
Cash from financing | 67.00K | 103.22% |
Net change in cash | -2.98M | 76.38% |
Free cash flow | -1.50M | 80.61% |
About
Founded
2015
Headquarters
Website
Employees
21
